Phase 2 DeLLphi-309 data show comparable activity in previously treated SCLC with less frequent dosing.
|Podcasts|April 8, 2022
Pharmacist Moms: Coffee With Suzy - Episode 11
Suzanne Soliman, PharmD, welcomed back guests Christina Madison, PharmD, FCCP, AAHIVP, and Joanna Lewis, PharmD.
Advertisement
On this week's episode, Suzanne Soliman, PharmD, BCMAS, welcomed back guests Christina Madison, PharmD, FCCP, AAHIVP, and Joanna Lewis, PharmD, to discuss the importance of identifying challenges and struggles that are commonly concealed, the importance of self care, and much more.
Advertisement
Related to this article
The most enduring resources a preceptor can give students are the confidence and tools to ask deeper questions.
A retrospective study of pharmacist-supported mirogabalin treatment highlights the need for careful evidence interpretation and sustained follow-up in cancer-related neuropathic pain.
The approval gives patients aged 12 years and older a once-daily oral pellet alternative to capsules for preventing hereditary angioedema (HAE) attacks.
REDEFINE 1 analyses presented at The Menopause Society 2026 meeting found mean weight loss of 23.1% to 26.7% across pre-, peri-, and postmenopausal women.
Ravulizumab is now the first C5 complement inhibitor approved for adults with primary IgA nephropathy at risk of disease progression.
A randomized clinical trial found that dedicated oncology pharmacist care reduced adverse drug reactions among patients with hematologic malignancies.
ENDURANCE trial finds fixed 2-year lenalidomide maintenance matches continuous therapy for standard-risk multiple myeloma survival, guiding oncology pharmacists on MM regimen toxicity.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
2
Operationalizing Therapy and Managing Hypophosphatemia Risk at UPMC
3
Oncology Pharmacists Reduce Adverse Drug Reactions in Hematologic Cancer Care
4
What Pharmacists Should Know About Sea Buckthorn for Respiratory Health
5